Healthcare -
Biotechnology - NASDAQ - US
$ 1.08
1.89 %
$ 69.4 M
Market Cap
-0.67
P/E
INZY - PRE-TAX INCOME
Pre-tax Income INZY - Inozyme Pharma, Inc.
-71.2 M
LAST VALUE
-12.11%
2 YEAR CAGR
-59.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR